Literature DB >> 12171848

Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure.

Chien Liang Wu1, Dine Ie Yang, Nai Yu Wang, Hsu Tah Kuo, Pai Zan Chen.   

Abstract

STUDY
OBJECTIVE: To study the correlation of bacteriology between quantitative cultures of protected specimen brush (PSB), BAL, and quantitative endotracheal aspirate (QEA) in ventilator-associated pneumonia (VAP) patients with treatment failure.
DESIGN: Prospective observational clinical study.
SETTING: A 15-bed medical ICU of tertiary medical center. PATIENTS: Forty-eight patients receiving mechanical ventilation with clinical suspected VAP who had been treated with antibiotics for at least 72 h without improvement. INTERVENTION: QEA, PSB, and BAL were performed with patients receiving antibiotics. The diagnostic thresholds for QEA, PSB, and BAL were 10(5), 10(3), and 10(4) cfu/mL, respectively. MEASUREMENTS AND
RESULTS: Microbial culture findings were positive in 24 BAL samples (50%), in 23 PSB samples (48%), and in 28 QEA samples (58%). The correlations between of QEA vs PSB and QEA vs BAL were significant (rho = 0.567 and rho = 0.620, p < 0.01, respectively). The most commonly isolated microorganisms were Acinetobacter baumannii (27%), Staphylococcus aureus (24%), Stenotrophomonas maltophilia (15%), and Pseudomonas aeruginosa (10%). Using the predetermined criteria, bacterial pneumonia was diagnosed in 28 of 48 suspected VAP episodes based on PSB and/or BAL results. The diagnostic efficiency of QEA at threshold of 10(5) cfu/mL had a sensitivity of 92.8% and a specificity of 80%.
CONCLUSIONS: QEA correlated with PSB and BAL in patients with suspected VAP who responded poorly to the existent antibiotic treatment. QEA missed only two cases of bacterial pneumonia diagnosed by invasive PSB and/or BAL with acceptable sensitivity and specificity. More importantly, QEA is noninvasive and easily repeatable. Early use of QEA is helpful to clinical physicians in decision making with regard to antibiotics use.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171848     DOI: 10.1378/chest.122.2.662

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

1.  Defining, treating and preventing hospital acquired pneumonia: European perspective.

Authors:  Antoni Torres; Santiago Ewig; Harmut Lode; Jean Carlet
Journal:  Intensive Care Med       Date:  2008-11-07       Impact factor: 17.440

2.  Mechanical ventilator as a major cause of infection and drug resistance in intensive care unit.

Authors:  Marwa M E Abd-Elmonsef; Dalia Elsharawy; Ayman S Abd-Elsalam
Journal:  Environ Sci Pollut Res Int       Date:  2017-02-23       Impact factor: 4.223

3.  Endotracheal aspirate and bronchoalveolar lavage fluid analysis: interchangeable diagnostic modalities in suspected ventilator-associated pneumonia?

Authors:  Johannes B J Scholte; Helke A van Dessel; Catharina F M Linssen; Dennis C J J Bergmans; Paul H M Savelkoul; Paul M H J Roekaerts; Walther N K A van Mook
Journal:  J Clin Microbiol       Date:  2014-07-30       Impact factor: 5.948

4.  Microbial profile of early and late onset ventilator associated pneumonia in the intensive care unit of a tertiary care hospital in bangalore, India.

Authors:  Saroj Golia; Sangeetha K T; Vasudha C L
Journal:  J Clin Diagn Res       Date:  2013-11-10

5.  Antibiotic susceptibility patterns of different bacteria isolated from patients with ventilator associated pneumonia (vap).

Authors:  Abdulrahman M Alqurashi
Journal:  J Family Community Med       Date:  2005-09

6.  Outcome of ventilator-associated pneumonia: Impact of antibiotic therapy and other factors.

Authors:  Noyal Mariya Joseph; Sujatha Sistla; Tarun Kumar Dutta; Ashok Shankar Badhe; Desdemona Rasitha; Subhash Chandra Parija
Journal:  Australas Med J       Date:  2012-02-29

7.  Incidence and risk factors of ventilator associated pneumonia in a tertiary care hospital.

Authors:  Mv Pravin Charles; Joshy M Easow; Noyal M Joseph; M Ravishankar; Shailesh Kumar; Sivaraman Umadevi
Journal:  Australas Med J       Date:  2013-04-30

Review 8.  Acinetobacter infections: a growing threat for critically ill patients.

Authors:  M E Falagas; E A Karveli; I I Siempos; K Z Vardakas
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

9.  Severe Hemoptysis Associated with Bacterial Pulmonary Infection: Clinical Features, Significance of Parenchymal Necrosis, and Outcome.

Authors:  Guillaume Carteaux; Damien Contou; Guillaume Voiriot; Antoine Khalil; Marie-France Carette; Martine Antoine; Antoine Parrot; Muriel Fartoukh
Journal:  Lung       Date:  2017-10-12       Impact factor: 2.584

10.  Incidence of multidrug-resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: a nine months' prospective study.

Authors:  Arindam Dey; Indira Bairy
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.